Maxcyte (MXCT) FCF Margin Growth (1y) (2021 - 2026)
Maxcyte (MXCT) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -1,716.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 192.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2,833.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 261.00 |
| 10 | Maxcyte | 120.23 Mn | 120.23 Mn | 8.08 Mn | 17,741.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,741.00 |
| Dec 31, 2025 | 11,651.00 |
| Sep 30, 2025 | -4,238.00 |
| Jun 30, 2025 | -8,052.00 |
| Mar 31, 2025 | -7,283.00 |
| Dec 31, 2024 | -4,052.00 |
| Sep 30, 2024 | 12,196.00 |
| Jun 30, 2024 | 133.00 |
| Mar 31, 2024 | -7,098.00 |
| Dec 31, 2023 | 26,710.00 |
| Sep 30, 2023 | 10,222.00 |
| Jun 30, 2023 | -16,082.00 |
| Mar 31, 2023 | -3,484.00 |
| Dec 31, 2022 | -41,417.00 |
| Sep 30, 2022 | -25,741.00 |
| Jun 30, 2022 | 14,012.00 |
| Mar 31, 2022 | 2,635.00 |
| Dec 31, 2021 | 8,369.00 |
| Sep 30, 2021 | -601.00 |